Dr. Laurence Klotz talks about using molecular biomarkers to predict if your prostate cancer is too aggressive for active surveillance.
Dr. Laurence Klotz talks about using molecular biomarkers to predict if your prostate cancer is too aggressive for active surveillance.
Conversations about prostate cancer.